CD147 expression in advanced cutaneous squamous cell carcinoma

Background: CD147 is upregulated in multiple cancer types, but its expression in advanced cutaneous squamous cell carcinoma (SCC) is unknown. Our purpose was to evaluate the expression patterns of CD147 and related monocarboxylate transporters (MCT1, MCT4) to determine their correlation with survival.

[1]  Yong Li,et al.  Co-expression of CD147/EMMPRIN with monocarboxylate transporters and multiple drug resistance proteins is associated with epithelial ovarian cancer progression , 2010, Clinical & Experimental Metastasis.

[2]  A. Longatto-Filho,et al.  Expression of Monocarboxylate Transporters 1, 2, and 4 in Human Tumours and Their Association with CD147 and CD44 , 2010, Journal of biomedicine & biotechnology.

[3]  J. Leonardi-Bee,et al.  Interventions for non-metastatic squamous cell carcinoma of the skin. , 2010, The Cochrane database of systematic reviews.

[4]  B. Zilberstein,et al.  The prognostic value of CD147/EMMPRIN is associated with monocarboxylate transporter 1 co-expression in gastric cancer. , 2009, European journal of cancer.

[5]  A. Longatto-Filho,et al.  Monocarboxylate Transporters 1 and 4 Are Associated with CD147 in Cervical Carcinoma , 2009, Disease markers.

[6]  Suzanne M Olbricht,et al.  Cutaneous squamous cell carcinoma. , 2008, Advances in dermatology.

[7]  A. Longatto-Filho,et al.  Increasing Expression of Monocarboxylate Transporters 1 and 4 Along Progression to Invasive Cervical Carcinoma , 2008, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[8]  A. Longatto-Filho,et al.  Increased expression of monocarboxylate transporters 1, 2, and 4 in colorectal carcinomas , 2008, Virchows Archiv.

[9]  N. Philp,et al.  Monocarboxylate transporter 4 regulates maturation and trafficking of CD147 to the plasma membrane in the metastatic breast cancer cell line MDA-MB-231. , 2007, Cancer research.

[10]  G. Sauter,et al.  High incidence of EMMPRIN expression in human tumors , 2006, International journal of cancer.

[11]  Adrian L Harris,et al.  Comparison of metabolic pathways between cancer cells and stromal cells in colorectal carcinomas: a metabolic survival role for tumor-associated stroma. , 2006, Cancer research.

[12]  M. Veness,et al.  Treatment recommendations in patients diagnosed with high-risk cutaneous squamous cell carcinoma. , 2005, Australasian radiology.

[13]  Li Yan,et al.  Roles of the multifunctional glycoprotein, emmprin (basigin; CD147), in tumour progression , 2005, Thrombosis and Haemostasis.

[14]  M. Urashima,et al.  CD147 and matrix metalloproteinase‐2 protein expression as significant prognostic factors in esophageal squamous cell carcinoma , 2004, Cancer.

[15]  E. Rosenthal,et al.  Expression of Extracellular Matrix Metalloprotease Inducer in Laryngeal Squamous Cell Carcinoma , 2003, The Laryngoscope.

[16]  T. Muramatsu,et al.  Loss of MCT1, MCT3, and MCT4 expression in the retinal pigment epithelium and neural retina of the 5A11/basigin-null mouse. , 2003, Investigative ophthalmology & visual science.

[17]  U. Rodeck,et al.  Regulation of intracellular pH in human melanoma: potential therapeutic implications. , 2002, Molecular cancer therapeutics.

[18]  T. Mark,et al.  The Period Prevalence and Costs of Treating Nonmelanoma Skin Cancers in Patients Over 65 Years of Age Covered by Medicare , 2001, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[19]  R K Jain,et al.  Hypoxia and acidosis independently up-regulate vascular endothelial growth factor transcription in brain tumors in vivo. , 2001, Cancer research.

[20]  T. Kanekura,et al.  Ultrastructural localization of basigin in normal human epidermis , 2001, Histochemistry and Cell Biology.

[21]  S. Bröer,et al.  The low-affinity monocarboxylate transporter MCT4 is adapted to the export of lactate in highly glycolytic cells. , 2000, The Biochemical journal.

[22]  A. Barclay,et al.  CD147 is tightly associated with lactate transporters MCT1 and MCT4 and facilitates their cell surface expression , 2000, The EMBO journal.

[23]  C. Gilles,et al.  Tumor Collagenase Stimulatory Factor (TCSF) Expression and Localization in Human Lung and Breast Cancers , 1997, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[24]  H. Guo,et al.  The human tumor cell-derived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily. , 1995, Cancer research.

[25]  C. Compton,et al.  AJCC Cancer Staging Manual , 2002, Springer New York.

[26]  M. Dewhirst,et al.  Elevated tumor lactate concentrations predict for an increased risk of metastases in head-and-neck cancer. , 2001, International journal of radiation oncology, biology, physics.

[27]  X. Li,et al.  Expression of emmprin by oral squamous cell carcinoma. , 2000, International journal of cancer.